pioglitazone has been researched along with inositol 1,4,5-trisphosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurosaki, E; Nakano, R; Shibasaki, M; Shikama, H; Shimaya, A; Shioduka, K | 1 |
1 other study(ies) available for pioglitazone and inositol 1,4,5-trisphosphate
Article | Year |
---|---|
YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Biological Transport; Carrier Proteins; Cell Differentiation; Deoxyglucose; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Gene Expression; Genes, Reporter; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Inositol 1,4,5-Trisphosphate; Insulin; Mice; Monocytes; Monosaccharide Transport Proteins; Muscle Proteins; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Phosphatidylinositol 3-Kinases; Pioglitazone; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1998 |